# Mike Fitzgibbons

> Mike Fitzgibbons is the CEO and Founder of Claritas Rx, a South San Francisco-based healthtech company that uses AI and real-world patient-level data to help biopharmaceutical companies track, understand, and support patients across the specialty drug treatment journey. Founded in 2011, Claritas Rx serves 20+ rare and specialty therapeutic areas and has appeared on Inc.'s 2025 list of America's Fastest-Growing Private Companies. Before founding Claritas Rx, Fitzgibbons spent seven years at Morgan Stanley as an equity research analyst covering pharma services and drug distribution, then joined Genentech where he worked on pricing strategy and led the Avastin marketing team - experiences that directly shaped his conviction that patient-level data, not aggregated reports, is what biopharma companies actually need.

- **Role:** CEO & Founder at Claritas Rx
- **Organizations:** Claritas Rx, Genentech, Morgan Stanley
- **Nationality:** American
- **Education:** High School, Milton Academy, Undergraduate, Amherst College
- **Known for:** Founded Claritas Rx in 2011 and grew it to 140 employees and ~$15M annual revenue, Named a Top Healthcare Technology CEO by The Healthcare Technology Report, Led Claritas Rx to Inc. 5000 America's Fastest-Growing Private Companies (2025)

## Career timeline

- **1993-1997** — Attended Amherst College
- **1997-2004** — Research Analyst at Morgan Stanley covering pharmaceutical services, drug distribution, and healthcare IT; earned CFA designation
- **2005-2008** — Joined Genentech as Group Manager in Pricing Strategy; work spanned lifecycle planning, commercial launch preparation, pricing strategy, and distribution strategy
- **2008-2011** — Group Product Manager on the Avastin Marketing Team at Genentech; deepened understanding of patient-level data challenges
- **2011** — Founded Claritas Rx, a specialty pharmacy data analytics platform based in South San Francisco
- **2021** — Claritas Rx secured significant growth equity investment from Questa Capital to expand product development, sales, and management team
- **2025** — Named a Top Healthcare Technology CEO by The Healthcare Technology Report; Claritas Rx named to Inc. 5000 Fastest-Growing Companies and Inc. Best Workplaces lists
- **2025** — Launched Access Analytics platform for real-time market access visibility; Patient Watchtower recognized by PM360 as a Best Innovation of 2025

## Achievements

- Founded Claritas Rx in 2011 and grew it to 140 employees and ~$15M annual revenue
- Named a Top Healthcare Technology CEO by The Healthcare Technology Report
- Led Claritas Rx to Inc. 5000 America's Fastest-Growing Private Companies (2025)
- Led Claritas Rx to Inc. Best Workplaces 2025 recognition
- Holds the Chartered Financial Analyst (CFA) designation
- Claritas Rx Patient Watchtower recognized on PM360 Magazine's Best Innovations of 2025 list
- Raised venture growth equity from Questa Capital in 2021
- Built a platform managing 5M+ patient-level data records across 20+ specialty therapeutic areas
- Achieved 95%+ accuracy in PHI (Protected Health Information) matching
- Helped clients increase first fill rates by 20% in complex cases

## Latest updates

- **2026-05** — Claritas Rx CTO Bhupesh Bajaj named to PM360 ELITE 100 list in the Data Miners category, reflecting continued team recognition
- **2025-08** — Claritas Rx named to Inc. 5000 list of America's Fastest-Growing Private Companies
- **2025-06** — Claritas Rx named to Inc. Best Workplaces 2025 list
- **2025-12** — Official CEO bio published on Claritas Rx website; named Top Healthcare Technology CEO by The Healthcare Technology Report
- **2025-01** — Launched Access Analytics platform for real-time market access visibility; Patient Watchtower named PM360 Best Innovation of 2025

## Links

- Website: https://claritasrx.com
- LinkedIn: http://www.linkedin.com/in/mfitzgibbons
- Twitter/X: https://twitter.com/claritas_rx?lang=en

---

Profile page: https://yespress.io/mike-fitzgibbons
Published by YesPress — https://yespress.io
Last updated: 2026-05-16